QA: Merus N.V. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651311_2020_Merus_N_V.pdf

Logs

warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 8.414324324324324, 'aggregate_val': 34833000, 'exp_sum': 3700000, 'exp_to_value': {'remainder_Revenues': 3700000}}

Graph

Absolute values for 0001651311, Merus N.V.

  xvar xval
0 AssetsCurrent 247,368,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,715,000
3 remainder_Assets 12,293,000
4 LiabilitiesCurrent 36,787,000
5 LiabilitiesNoncurrent 3,872,000
6 remainder_Liabilities 91,417,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 34,110,000
9 ResearchAndDevelopmentExpense 55,680,000
10 remainder_Expenses 194,000
11 remainder_Revenues 34,833,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -1,308,000
  yvar yval
0 Assets 263,376,000
1 Liabilities 132,076,000
2 Expenses 89,984,000
3 Revenues 34,833,000
4 StockholdersEquity 131,300,000
5 NetIncome -55,151,000
6 ComprehensiveNetIncome -55,805,000
7 BaseVar 260,788,500
8 EconomicCapitalRatio 0.860

Edgar->Model Mapping

Feature Distribution

Change over Time